برنامه ای برای تسریع در درمان بیماری نوروفیبروماتوز در دانشکده پزشکی دانشگاه جان هاپکینز

به تدریج مطالب مربوط به این گروه که در تلاش برای شتاب در درمان بیماری نوروفیبروماتوز هستند، ترجمه می شود.Seeker Spotlight: Neurofibromatosis Therapeutic Accelerations Program (NTAP) at Johns Hopkins The Neurofibromatosis Therapeutic Accelerations Program (NTAP) at Johns Hopkins launched a Challenge in mid-January which seeks creative ways to identify which plexiform neurofibroma tumors will undergo significant growth in individuals who have neurofibromatosis type 1 (a syndrome with a well-defined genetic cause but complex biology at the tissue level). We recently spoke with Dr. Jaishri Blakeley, Assistant Professor of Neurology, Neurosurgery and Oncology at the Johns Hopkins University School of Medicine and the Director of the Johns Hopkins Comprehensive Neurofibromatosis Center, about this important Challenge which is scheduled to run through February 13, 2013.